Menu
Close
Home
About ImmuneOnco
About Us
Core Team
Development Strategy
ESG Report
Scientific Technology and R&D
Technology Platform
Product Pipeline
Latest Development
Company News
Investor Relations
Information Disclosure
Presentations
Corporate Governance
Investor Calendar
IR Contact
Join Us
Contact Us
Global
CN
TC
Home
CN
TC
About ImmuneOnco
About Us
Core Team
Development Strategy
ESG Report
Scientific Technology and R&D
Technology Platform
Product Pipeline
Scientific News
Company News
Investor Relations
Information Disclosure
Corporate Governance
Investor Calendar
Presentation Materials
Stock Information
Analyst Coverage
IR Contact
Email Subscription Center
Join Us
Contact Us
>
×
Investor Relations
Information Disclosure
Announcements and Circulars
Analyst Report
Financial Reports
Listing Documents
Year
2026
2025
2024
2023
Month
12
11
10
09
08
07
06
05
04
03
02
01
2025-12-03
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD
2025-12-03
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD
2025-11-27
VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE PHASE III CLINICAL STUDY PROTOCAL OF IMM0306 FOR THE TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA FROM CDE
2025-11-27
VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE PHASE III CLINICAL STUDY PROTOCAL OF IMM0306 FOR THE TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA FROM CDE
2025-11-20
DISCLOSEABLE TRANSACTIONS - REDEMPTIONS AND SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
2025-11-20
DISCLOSEABLE TRANSACTIONS - REDEMPTIONS AND SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
2025-11-18
ARTICLES OF ASSOCIATION
2025-11-18
ARTICLES OF ASSOCIATION
2025-11-17
AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2025-11-17
AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2025-11-07
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD
2025-11-07
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD
2025-11-06
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2025
2025-10-23
VOLUNTARY ANNOUNCEMENT - FIRST PATENT DOSED IN THE PHASE IB/II CLINICAL TRIAL OF IMM2510 IN COMBINATION WITH IMM01
2025-10-23
VOLUNTARY ANNOUNCEMENT - FIRST PATENT DOSED IN THE PHASE IB/II CLINICAL TRIAL OF IMM2510 IN COMBINATION WITH IMM01
2025-10-16
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE
2025-10-16
Next Day Disclosure Return
2025-10-16
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE
2025-10-09
PLACING OF NEW H SHARES UNDER GENERAL MANDATE
2025-10-09
PLACING OF NEW H SHARES UNDER GENERAL MANDATE
总计 182
1
2
3
4
5
6
7
8
9
10
